[1]Burden of valvular heart disease: a population based study. Lancet. 2006; 368:1005-11.
[2]Aortic regurgitation: assessment with 64-section CT. Radiology. 2000; 245:111-21.
[3]When should Doppler determined valve area be better than the Gorlin formula?. Variation in hydraulic constants in low flow states. J Am Coll Cardiol. 1987; 9:1294-305.
[4]Quantification of aortic valve stenosis in MRI: comparison of steady state free precession and fast low angle shot sequences. Eur Radiol. 2007; 17:1284-90.
[5]Valvular heart disease: what does cardiovascular MRI add?. Eur Radiol. 2008; 18:197-208.
[6]Ventricular volume and mass by CMR. J Cardiovasc Magn Reson. 2002; 4:507-13.
[7]Assessment of functional anatomy of the mitral valve in patients with mitral regurgitation with cine magnetic resonance imaging: comparison withtransesophageal echocardiography and surgical results. Eur Radiol. 2007; 17:3189-98.
[8]Tumors of the cardiac valves: imaging findings in magnetic resonance imaging, electron beam computed tomography and echocardiography. Eur Radiol. 2000; 10:443-9.
[9]How we perform delayed enhancement imaging. J Cardiovasc Magn Reson. 2003; 5:505-14.
[10]Magn Reson Imaging Clin North Am. 1999; 7:699-715.
[11]Flow measurement by magnetic resonance: a unique asset worth optimizing. J Cardiovasc Magn Reson. 2007; 9:1-6.
[12]Phase contrast ultrashort TE: a more reliable technique for measurement of high velocity turbulent stenotic jets. Magn Res Med. 2009; 62:626-36.
[13]Cardiovsacular magnetic resonance imaging for valvular hear disease. Technique and validation. Circulation. 2009; 119:468-78.
[14]Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques. Heart. 2004; 90:893-901.
[15]imaging of valvular heart disease: display and imaging parameters affect the size of the signal void caused by valvular regurgitation. AJR Am J Roentgenol. 1990; 155:723-7.
[16]Towards comprenhensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008; 10:61-8.
[17]2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2008;52:e1-142.
[18]Quantitative evaluation of aortic regurgitation in asymptomatic patients using CMR predicts long-term outcome. Heart Lung Circ. 2009; 18(Suppl 12):S5-6.
[19]Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc Imaging. 2008; 1:104-13.
[20]Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualization of focal fibrosis. Heart. 2006; 92:1447-51.
[21]Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging studies in normal and impaired left ventricular function. J Am Coll Cardiol. 2006; 48:2002-11.
[22]Role of magnetic resonance imaging in different ways of presentations of Ebstein's anomaly. J Cardiovasc Med. 2008; 9:628-30.
[23]Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J. 2002; 20:1519-24.
[24]Assessment of Ebstein anomaly by cardiovascular magnetic resonance. Eur Heart J. 2007; 28Suppl:99.
[25]Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993; 329:593-9.
[26]Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010; 31:2915-57.
[27]Wald R, Redington AN, Pereira A, Provost YL, Paul NS, Oechslin EN, et al. Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume? Eur Heart J. 2009;30:356-1.
[28]Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantification by nuclear magnetic resonance velocity mapping. Circulation. 1993; 88:2257-66.
[29]Intra-observer and interobserver variability of biventricular function, volumes and mass in patients with congenital heart disease measured by CMR imaging. Int J Cardiovasc Imaging. 2010; 26:57-64.
[30]Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007; 116:545-51.
[31]Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006; 113:405-13.